IndraLab

Statements


CYLD inhibits HDAC6. 17 / 18
| 12 5

sparser
"CYLD interacts with p62 directly and CYLD can directly inactivate HDAC6, thereby controlling autophagy [ xref ]."

reach
"We further found by immunofluorescence microscopy a colocalization of CYLD and HDAC6 at the centrosome and basal body and, interestingly, loss of Cyld promoted the localization of HDAC6 at the centrosome and basal body."

reach
"CYLD negatively regulates the cell cycle by inactivating HDAC6, a histone deactylase, and increases the concentration of acetylated tubulin."

reach
"In addition, CYLD inactivates HDAC6, which modulates cilia length [XREF_BIBR]."

sparser
"CYLD also binds and inactivates the histone deacetylase 6 (HDAC6), therefore driving tubulin acetylation and primary cilia formation ( Yang et al., 2014 )."

reach
"CYLD also inhibits HDAC6, leading to increased acetylated tubulin and less cellular motility, as we saw before [XREF_BIBR]."

reach
"In the normal conditions, CYLD inactivates HDAC6 to promote primary ciliary homeostasis as well as inhibit EMT program; however, during pulmonary fibrosis, CYLD deficiency relieves its inhibitory interaction with HDAC6, thereby leading to primary disassembly and the EMT program (Fig. 6L)."

reach
"Studies have identified that CYLD is able to inhibit the function of class II histone deacetylases HDAC6 and HDAC7 by interacting with their catalytic domain [26–28]."

reach
"Taken together, these findings suggest that CYLD, TSA, and tubacin act within the same pathway to inhibit HDAC6, which results in elevated levels of acetylated alpha-tubulin."

reach
"Moreover, CYLD is also able to inhibit HDAC6, a member of the HDAC family whose major substrate is alpha-tubulin, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation XREF_BIBR."

reach
"CYLD mediated HDAC6 inhibition was observed to enhance its association with the MTs, reduce the rate of cytokinesis, and delay cell cycle (XREF_FIG)."

sparser
"Moreover, CYLD is also able to inhibit HDAC6, a member of the HDAC family whose major substrate is α-tubulin, has become a target for drug development to treat cancer due to its major contribution in oncogenic cell transformation xref ."

reach
"HDAC6 interacts with and is inhibited by the deubiquitinating enzyme cylindromatosis (CYLD) at the perinuclear region, significantly delaying the G1-to-S-phase transition, and in the midbody where it [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

sparser
"In addition, CYLD inactivates HDAC6, which modulates cilia length [ xref ]."

reach
"CYLD inhibits HDAC6 activity by binding to its catalytic domains."

sparser
"CYLD also inhibits HDAC6, leading to increased acetylated tubulin and less cellular motility, as we saw before [ xref ]."

reach
"CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin."